These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8882165)

  • 21. Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells.
    Gazit D; Ebner R; Kahn AJ; Derynck R
    Mol Endocrinol; 1993 Feb; 7(2):189-98. PubMed ID: 8385738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells.
    Slootweg MC; van Buul-Offers SC; Herrmann-Erlee MP; van der Meer JM; Duursma SA
    J Endocrinol; 1988 Mar; 116(3):R11-3. PubMed ID: 3351425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone receptors in isolated rat adipocytes.
    Gavin JR; Saltman RJ; Tollefsen SE
    Endocrinology; 1982 Feb; 110(2):637-43. PubMed ID: 6276142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for involvement of the carboxy terminus of helix 1 of growth hormone in receptor binding: use of charge reversal mutagenesis to account for calcium dependence of binding and for design of higher affinity analogues.
    Rowlinson SW; Barnard R; Bastiras S; Robins AJ; Senn C; Wells JR; Brinkworth R; Waters MJ
    Biochemistry; 1994 Oct; 33(39):11724-33. PubMed ID: 7918389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural characteristics of growth hormone receptors on mouse 3T3 cells having different biological responses to growth hormone.
    Uchida E; Hayakawa T; Niimi S; Tanaka A; Morikawa M
    J Mol Endocrinol; 1989 Nov; 3(3):239-45. PubMed ID: 2590385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of retinoic acid- and cell-dependent sequences which regulate zif268 gene expression in osteoblastic cells.
    Suva LJ; Towler DA; Harada S; Gaub MP; Rodan GA
    Mol Endocrinol; 1994 Nov; 8(11):1507-20. PubMed ID: 7877619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of lactogenic receptors in female hamster liver due to the human growth hormone analog produced by plerocercoids of the tapeworm, Spirometra mansonoides.
    Phares CK; Booth BJ
    Endocrinology; 1986 Mar; 118(3):1102-9. PubMed ID: 3004894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
    Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
    Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.
    Rowlinson SW; Waters MJ; Lewis UJ; Barnard R
    Endocrinology; 1996 Jan; 137(1):90-5. PubMed ID: 8536647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human liver growth hormone receptor and plasma binding protein: characterization and partial purification.
    Hocquette JF; Postel-Vinay MC; Djiane J; Tar A; Kelly PA
    Endocrinology; 1990 Oct; 127(4):1665-72. PubMed ID: 2205475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukemia inhibitory factor binds with high affinity to preosteoblastic RCT-1 cells and potentiates the retinoic acid induction of alkaline phosphatase.
    Rodan SB; Wesolowski G; Hilton DJ; Nicola NA; Rodan GA
    Endocrinology; 1990 Oct; 127(4):1602-8. PubMed ID: 2119291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guinea pig serum contains a specific high affinity growth hormone-binding protein with novel ligand specificity.
    Ymer SI; Stevenson JL; Herington AC
    Endocrinology; 1997 Sep; 138(9):3577-86. PubMed ID: 9275038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine 3',5'-monophosphate-dependent loss of growth hormone binding in rat adipocytes.
    Gorin E; Honeyman TW; Tai LR; Goodman HM
    Endocrinology; 1988 Jul; 123(1):328-34. PubMed ID: 2838258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose retinoic acid modulates rat calvarial osteoblast biology.
    Song HM; Nacamuli RP; Xia W; Bari AS; Shi YY; Fang TD; Longaker MT
    J Cell Physiol; 2005 Jan; 202(1):255-62. PubMed ID: 15389522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone (GH)-binding proteins in GH-resistant guinea pigs.
    Hull KL; Janssens WC; Baumbach WR; Harvey S
    Growth Regul; 1996 Sep; 6(3):165-75. PubMed ID: 8894650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding and structural characteristics of a soluble lactogen-binding protein from rabbit mammary-gland cytosol.
    Ymer SI; Herington AC
    Biochem J; 1986 Aug; 237(3):813-20. PubMed ID: 3800919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic binding of human and bovine growth hormones and ovine prolactin in the dwarf "little" mouse.
    Herington AC; Harrison D; Graystone J
    Endocrinology; 1983 Jun; 112(6):2032-8. PubMed ID: 6303755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.